stockrowPTC Therapeutics, Inc.
PTCT Healthcare Biotechnology
PTC Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.7 billion, up 114.5% from fiscal 2024.
- Revenue
- +69.6%
- EPS
- −409.7%
- Free cash flow
- +90.3%
- Total debt
- +19.3%
Quarter to September 2026, against a year earlier
Follow PTCT
Alert me
PTC Therapeutics, Inc. (PTCT) Operating margin
PTC Therapeutics, Inc.'s operating margin over the twelve months to 30 September 2026 was 12.8%, down 37.3 percentage points from fiscal 2025 (50.1%). Over the past ten years it has ranged from −454.6% (fiscal 2015) to 50.1% (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 50.1% | 87.59 |
| FY2024 | −37.5% | 9.36 |
| FY2023 | −46.9% | 17.17 |
| FY2022 | −64.0% | 5.49 |
| FY2021 | −69.5% | 43.87 |
| FY2020 | −113.4% | (34.83) |
| FY2019 | −78.6% | (34.86) |
| FY2018 | −43.7% | (10.63) |
| FY2017 | −33.1% | 126.60 |
| FY2016 | −159.7% | 294.91 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 7.02% | (34.30) |
| Jun 2026 | 41.3% | 24.82 |
| Mar 2026 | 16.5% | 59.83 |
| Dec 2025 | −43.3% | (44.76) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| PTCT PTC Therapeutics, Inc. | 12.8% |
| COGT Cogent Biosciences, Inc. compare | 0.00% |
| KOD Kodiak Sciences Inc. compare | 0.00% |
| IMVT Immunovant, Inc. compare | 0.00% |
| MANE Veradermics Incorporated compare | 0.00% |
| SRRK Scholar Rock Holding Corporation compare | 0.00% |
| BLTE Belite Bio, Inc. Sponsored ADR compare | 0.00% |
| MIRM Mirum Pharmaceuticals, Inc. compare | −133.6% |
| CGON CG Oncology, Inc. compare | −4,056.2% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on PTCT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement